Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: A long-term followup from disease onset

Arthritis Care and Research

Volumn 65, Issue 1, 2013, Pages 78-87

  Ajeganova, Sofia ^a   Andersson, Maria L ^b   Hafström, Ingiäld ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Spenshult Hospital for Rheumatic Diseases   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ASTHMA; BODY MASS; CEREBROVASCULAR ACCIDENT; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DAS28; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EMPHYSEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; ONSET AGE; REMISSION; RHEUMATOID ARTHRITIS; TRANSIENT ISCHEMIC ATTACK; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADIPOSITY; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; WAIST CIRCUMFERENCE;

EID: 84861675435     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21710     Document Type: Article

References (44)

1. Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C,. Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken) 2010; 62: 1128-43.
2. Conaghan PG,. Predicting outcomes in rheumatoid arthritis. Clin Rheumatol 2011; 30 Suppl: S41-7.
3. Elkan AC, Engvall IL, Cederholm T, Hafstrom I,. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 2009; 48: 315-22.
4. Walsmith J, Roubenoff R,. Cachexia in rheumatoid arthritis. Int J Cardiol 2002; 85: 89-99.
5. Escalante A, Haas RW, del Rincon I,. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165: 1624-9.
6. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE,. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 2004; 50: 3450-7.
7. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, Jamurtas AZ, et al. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 242-5.
8. Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G,. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 2350-5.
9. Westhoff G, Rau R, Zink A,. Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 2007; 56: 3575-82.
10. Van der Helm-van Mil AH, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW,. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 2008; 67: 769-74.
11. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452.
12. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Nevill AM, Douglas KM, Jamurtas A, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 2007; 66: 1316-21.
13. Svensson B, Schaufelberger C, Teleman A, Theander J, for the BARFOT Study Group. Remission and response to early treatment of RA assessed by the Disease Activity Score. Rheumatology (Oxford) 2000; 39: 1031-6.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
15. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
16. Van Gestel AM, Haagsma CJ, van Riel PL,. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845-50.
17. Prevoo ML, van Gestel AM, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL,. Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the Disease Activity Score. Br J Rheumatol 1996; 35: 1101-5.
18. Ekdahl C, Eberhardt K, Andersson SI, Svensson B,. Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988; 17: 263-71.
19. Alberti KG, Zimmet P, Shaw J,. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-62.
20. Statistics in Sweden. Living conditions survey (ULF). 2011. URL: www.scb.se.
21. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008; 59: 807-15.
22. Tilg H, Moschen AR,. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Rev Immunol 2006; 6: 772-83.
23. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, et al. Circulating tumor necrosis factor α concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999; 48: 1332-5.
24. Eder K, Baffy N, Falus A, Fulop AK,. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009; 58: 727-36.
25. Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, et al. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol 2006; 101: 1824-33.
26. Giles JT, Bartlett SJ, Andersen R, Thompson R, Fontaine KR, Bathon JM,. Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2632-41.
27. Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007; 66: 28-33.
28. Klaasen R, Wijbrandts CA, Gerlag DM, Tak PP,. Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum 2011; 63: 359-64.
29. Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM,. Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 2008; 59: 1407-15.
30. Smolen JS, Aletaha D,. Patients with rheumatoid arthritis in clinical care. Ann Rheum Dis 2004; 63: 221-5.
31. Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D, et al. The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Ann Rheum Dis 2012; 71: 836-44.
32. Visser M, Langlois J, Guralnik JM, Cauley JA, Kronmal RA, Robbins J, et al. High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr 1998; 68: 584-90.
33. Hitt HC, McMillen RC, Thornton-Neaves T, Koch K, Cosby AG,. Comorbidity of obesity and pain in a general population: results from the Southern Pain Prevalence Study. J Pain 2007; 8: 430-6.
34. Garcia-Poma A, Segami MI, Mora CS, Ugarte MF, Terrazas HN, Rhor EA, et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26: 1831-5.
35. Hassan MK, Joshi AV, Madhavan SS, Amonkar MM,. Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord 2003; 27: 1227-32.
36. Engel SG, Crosby RD, Kolotkin RL, Hartley GG, Williams GR, Wonderlich SA, et al. Impact of weight loss and regain on quality of life: mirror image or differential effect? Obes Res 2003; 11: 1207-13.
37. Michaud K, Wolfe F,. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 885-906.
38. Despres JP, Lemieux I,. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.
39. Symmons DP, Gabriel SE,. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011; 7: 399-408.
40. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV,. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167-72.
41. Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A,. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
42. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-7.
43. Simard JF, Mittleman MA,. Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older. J Rheumatol 2007; 34: 469-73.
44. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, Jamurtas AZ, et al. Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. Arthritis Res Ther 2008; 10: R59.